Galectin Therapeutics, Inc. (GALT)
2.74
-0.02
(-0.72%)
USD |
NASDAQ |
Feb 17, 16:00
2.75
+0.01
(+0.36%)
Pre-Market: 20:00
Galectin Therapeutics Market Cap : 176.66M for Feb. 17, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.883B |
| Alnylam Pharmaceuticals, Inc. | 44.11B |
| Savara, Inc. | 1.166B |
| BioMarin Pharmaceutical, Inc. | 11.52B |
| Imunon, Inc. | 6.896M |
Market Cap Related Metrics
| Price | 2.74 |
| Earnings Yield | -21.58% |